MMM

3m Co Health Care Surgical & Medical Instruments & Apparatus S&P 500Dow 30Russell 3000
$174.34Close $92.4BMarket cap $139.86 – $182.9852-week range Jan 19, 2027Next report · estimated

Highlights

Strengths

  • Near its high 5% below its 52-week high
  • Earnings growing EPS +70% year on year, faster than the quarter before (+36 pts)

Cautions

  • Trend not confirmed 6 of 8 conditions · under 30% off the low, RS under 70

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 20, 2026
Off 12-month high 5%
1wk up 0.5% price change
1mo up 6.2% price change
12-month return up 7% market up 11% · its own down 3%
F-score 5 / 9 Mixed
Altman Z 4.38 Low risk
P/E 28.4× price / earnings
PEG — P/E / EPS growth
P/B 19.7× price / book
Earnings yield up 4.7% EBIT / enterprise value
Cheaper than 34% of the market · expensive
Revenue growth up 2% year on year
EPS growth up 70% latest quarter · +36 pts
Sales growth up 1% latest quarter · -1 pts
ROE up 76% return on equity
Free cash margin up 6% $1.4B FCF
D/E 2.32 long-term debt / equity
Net debt / EBITDA 1.0×
Interest cover 10.3×EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • profits not fully backed by cash
  • took on more long-term debt
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Repair signals

  • Revenue reaccelerating (-0% then +2%)

Trade setup

ATR% 2.3% $3.99 a day · 2×ATR $166.36
RS 61 / 99 vs the universe
Trend 6 / 8 under 30% off the low, RS under 70
Relative volume 1.0× vs 50-day average
Up/down volume 1.02 50 sessions
Implied move — no scheduled report
Trend template · 6 of 8
  • At least 30% above the 52-week low: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Profit not backed by cash Reported profit of $3.2B came with $2.3B of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
  • Gross margin narrowing Gross margin fell from 41.2% to 39.9%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Oct 20, 2026
Results reaction Oct 20, 2026+7% vs market2 sessions after results
Options $3.1M25.5% IV · activity

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $24.9B +2% on FY2024
$0 $50B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $32.2B FY2021 · $35.4B FY2022 · $26.2B FY2023 · $24.6B FY2024 · $24.6B FY2025 · $24.9B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $3.2B -22% on FY2024
-$10B $0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $5.4B FY2021 · $5.9B FY2022 · $5.8B FY2023 · -$7.0B FY2024 · $4.2B FY2025 · $3.2B
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $1.4B +119% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $6.6B FY2021 · $5.9B FY2022 · $3.8B FY2023 · $5.1B FY2024 · $638.0M FY2025 · $1.4B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 40%
  • Net 13%
  • Free cash 6%
-50% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 48% · Net 17% · Free cash 21% FY2021 · Gross 47% · Net 17% · Free cash 17% FY2022 · Gross 39% · Net 22% · Free cash 15% FY2023 · Gross 39% · Net -28% · Free cash 21% FY2024 · Gross 41% · Net 17% · Free cash 3% FY2025 · Gross 40% · Net 13% · Free cash 6%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $5.7B net debt
  • Cash
  • Long-term debt
$0 $20B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $4.6B · Long-term debt $18.0B FY2021 · Cash $4.6B · Long-term debt $16.1B FY2022 · Cash $3.7B · Long-term debt $14.0B FY2023 · Cash $5.9B · Long-term debt $13.1B FY2024 · Cash $5.6B · Long-term debt $11.1B FY2025 · Cash $5.2B · Long-term debt $10.9B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 530.28m -8.2% since FY2020
577.75m 530.28m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 577.75m FY2021 · 571.85m FY2022 · 549.25m FY2023 · 552.58m FY2024 · 539.47m FY2025 · 530.28m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $32.2B $35.4B $26.2B $24.6B $24.6B $24.9B
Gross margin 48% 47% 39% 39% 41% 40%
Operating income $7.2B $7.4B $4.4B -$10.7B $4.8B $4.6B
Net income $5.4B $5.9B $5.8B -$7.0B $4.2B $3.2B
Net margin 17% 17% 22% -28% 17% 13%
Earnings per share $9.36 $10.12 $10.18 -$12.63 $7.55 $6.00
Free cash flow $6.6B $5.9B $3.8B $5.1B $638.0M $1.4B
Free cash margin 21% 17% 15% 21% 3% 6%
Cash $4.6B $4.6B $3.7B $5.9B $5.6B $5.2B
Long-term debt $18.0B $16.1B $14.0B $13.1B $11.1B $10.9B
Shareholders' equity $12.9B $15.0B $14.7B $4.8B $3.8B $4.7B
Shares outstanding 577.75m 571.85m 549.25m 552.58m 539.47m 530.28m

What options price now

Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
$164 – $184 ±5.7% by Nov 27, 2026
Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
About the same 25.5% priced · 27.9% recent
Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
Choppier
Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
past week: costs more
Positioning
Premium traded
$3.1M calls $2.4M · puts $670,000 · latest session
Puts against calls, by premium Money spent on puts divided by money spent on calls. Measured in dollars rather than contracts on purpose: counting contracts treats a hundred cheap lottery tickets as more meaningful than one large position, which is backwards. Methodology
0.28× -0.12 over the week
Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
calls -5.99k · puts -6.93k past week

For options traders: ATM IV 25.5% (-1.0% 1w) · 1m ÷ 3m IV 1.06 · 25Δ skew 4.3 pts · Net GEX $23.1M

Most traded contracts

No contract passed the liquidity filters this week.

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 20, 2026 Quarterly ↗ Sep 30, 2026 20d
Jul 21, 2026 Quarterly ↗ Jun 30, 2026 21d
Apr 21, 2026 Quarterly ↗ Mar 31, 2026 21d
Feb 3, 2026 Annual ↗ Dec 31, 2025 34d
Oct 21, 2025 Quarterly ↗ Sep 30, 2025 21d
Jul 18, 2025 Quarterly ↗ Jun 30, 2025 18d
Apr 22, 2025 Quarterly ↗ Mar 31, 2025 22d
Feb 5, 2025 Annual ↗ Dec 31, 2024 36d
Oct 22, 2024 Quarterly ↗ Sep 30, 2024 22d
Jul 26, 2024 Quarterly ↗ Jun 30, 2024 26d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Feb 7, 2024 Annual ↗ Dec 31, 2023 38d

Current reports